Sabine Bender

538 total citations
10 papers, 401 citations indexed

About

Sabine Bender is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sabine Bender has authored 10 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sabine Bender's work include Peptidase Inhibition and Analysis (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and HER2/EGFR in Cancer Research (2 papers). Sabine Bender is often cited by papers focused on Peptidase Inhibition and Analysis (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and HER2/EGFR in Cancer Research (2 papers). Sabine Bender collaborates with scholars based in Switzerland, Germany and United States. Sabine Bender's co-authors include Nissi Varki, Peter Forsyth, Gary A. Truitt, Stephen A. Margosiak, David R. Shalinsky, Dylan R. Edwards, Colleen D. McDermott, Helen Y. Zou, Alexander W. Wood and Krzysztof Appelt and has published in prestigious journals such as Molecular Cell, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Sabine Bender

10 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sabine Bender Switzerland	7	227	167	156	42	36	10	401
Leyre Larzábal Spain	11	299 1.3×	177 1.1×	251 1.6×	28 0.7×	29 0.8×	14	519
Sophie de Boüard France	8	209 0.9×	93 0.6×	111 0.7×	34 0.8×	24 0.7×	9	408
Steven King United States	3	288 1.3×	130 0.8×	116 0.7×	19 0.5×	43 1.2×	8	469
Emma Risson United States	4	142 0.6×	102 0.6×	189 1.2×	57 1.4×	27 0.8×	5	325
Anne‐Lise Børresen‐Dale Norway	11	323 1.4×	262 1.6×	315 2.0×	36 0.9×	12 0.3×	17	627
Meleah Cameron United States	3	141 0.6×	130 0.8×	244 1.6×	51 1.2×	52 1.4×	6	386
Tatiana Eliseeva United States	3	162 0.7×	101 0.6×	190 1.2×	24 0.6×	50 1.4×	4	363
Ivana Heřmanová Czechia	9	198 0.9×	84 0.5×	97 0.6×	35 0.8×	22 0.6×	16	406
Kerstin Schlüter Germany	9	191 0.8×	86 0.5×	267 1.7×	100 2.4×	48 1.3×	9	505
Sarah B. Crist United States	7	298 1.3×	108 0.6×	235 1.5×	85 2.0×	32 0.9×	10	452

Countries citing papers authored by Sabine Bender

Since Specialization

Citations

This map shows the geographic impact of Sabine Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Bender more than expected).

Fields of papers citing papers by Sabine Bender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Bender. The network helps show where Sabine Bender may publish in the future.

Co-authorship network of co-authors of Sabine Bender

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Bender. A scholar is included among the top collaborators of Sabine Bender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Bender. Sabine Bender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Dächert, Christopher, Maximilian Muenchhoff, Alexander Graf, et al.. (2022). Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants. Medical Microbiology and Immunology. 211(1). 71–77. 22 indexed citations

Bender, Sabine, et al.. (2021). Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells. Frontiers in Oncology. 11. 664462–664462. 2 indexed citations

Bender, Sabine, et al.. (2021). The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes Radiotherapy-induced VEGF Release and Sensitizes Non–Small Cell Lung Cancer for Radiotherapy. Cancer Research Communications. 1(3). 164–177. 7 indexed citations

Riesterer, Oliver, Martin Pruschy, Sabine Bender, et al.. (2020). Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study. Radiotherapy and Oncology. 150. 62–69. 3 indexed citations

Nytko, Katarzyna J., et al.. (2017). The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy. Oncotarget. 8(14). 23702–23712. 24 indexed citations

Sharma, Ashish, Sabine Bender, Martina Zimmermann, et al.. (2016). Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non–Small Cell Lung Cancer. Clinical Cancer Research. 22(17). 4428–4439. 35 indexed citations

Bender, Sabine, Animesh Sharma, Angela Broggini‐Tenzer, & Martin Pruschy. (2016). Secretome signature identifies ADAM17 as novel target for radiosensitization of non-small cell lung cancer. European Journal of Cancer. 61. S160–S160. 1 indexed citations

Broggini‐Tenzer, Angela, Ashish Sharma, Katarzyna J. Nytko, et al.. (2015). Combined Treatment Strategies for Microtubule Stabilizing Agent-Resistant Tumors. JNCI Journal of the National Cancer Institute. 107(4). 16 indexed citations

Young, Lucy C., Nicole Hartig, Juan A. Osés-Prieto, et al.. (2013). An MRAS, SHOC2, and SCRIB Complex Coordinates ERK Pathway Activation with Polarity and Tumorigenic Growth. Molecular Cell. 52(5). 679–692. 89 indexed citations

10.

Shalinsky, David R., Helen Y. Zou, Colleen D. McDermott, et al.. (1999). Broad Antitumor and Antiangiogenic Activities of AG3340, a Potent and Selective MMP Inhibitor Undergoing Advanced Oncology Clinical Trials. Annals of the New York Academy of Sciences. 878(1). 236–270. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact